SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-120079
Filing Date
2024-11-01
Accepted
2024-11-01 16:15:08
Documents
1
Period of Report
2024-10-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6651
  Complete submission text file 0000950170-24-120079.txt   8845
Mailing Address GOOIMEER 235, 1411 DC NAARDEN P7 00000
Business Address GOOIMEER 235, 1411 DC NAARDEN P7 00000 31 35 6993015
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting) CIK: 0001911047 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41854 | Film No.: 241419261

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 0031356993015
Forbion Growth Management B.V. (Reporting) CIK: 0001918318 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41854 | Film No.: 241419260

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)